Roche Diabetes Care at the virtual ATTD 2021 meeting

Wednesday, June 2, 2021 - Saturday, June 5, 2021

Order Publications and Solution BrochuresUnicon
 

Exhibit info

We look forward to welcoming you to the virtual Roche Diabetes Care presence! 

Take a look at our virtual booth and visit our Showroom, where you may chat with booth staff on integrated Personalised Diabetes Management. Feel free to contact us for more information and visit our website

Location

Virtual meeting

Open congress website

Exhibition

Virtual exhibition hall

Roche Diabetes Care Showroom

Opening hours

Wednesday, June 2: 13:20 - 22:35


Thursday, June 3: 13:00 - 21:00


Friday, June 4: 13:00 - 21:00


Saturday, June 5: 13:00 - 21:00

 

Advancing value-based personalised diabetes care in challenging times

Thursday, June 3, 2021
Time: 12:20 - 13:50
Chairs: Julia Mader (Austria), Rolf Hinzmann (Germany)

Speaker

Chair

Julia Mader
Medical University of Graz, Austria

Chair

Rolf Hinzmann
Roche Diabetes Care GmbH, Germany

Seeing healthcare systems change towards paying for value-based care

Wendelin Schramm
Hochschule Heilbronn, Germany

Full abstract

Providing integrated Personalised Diabetes Managment with the RocheDiabetes Care Platform

Ann Buskirk
Roche Diabetes Care, USA

Full abstract

Personalising Insulin therapy using smart pumps, pens and automated Insulin delivery systems

Julia Mader
Medical University of Graz, Austria

Full abstract

Using self-learning algorithmus to generate additional medical value from diabetes data

Lars Böhm
IBM, Switzerland

 

Abstracts & Posters

Validation of a predictive physiological model to support personalized medicine in type 2 diabetes

Wednesday, June 2: 18:45 - 18:55
Presenter: Chinmay Manohar, USA

Author: Chinmay Manohar, USA; Heather Mikulski, Spain; Samer Dajani, USA; Guido Freckmann, Germany; Eckhard Salzsieder, Germany; Lutz Vogt, Germany

Full abstract

Patient reported preferences from the Pro Solo: Novel Patch pump clinical trial

Thursday, June 3: 20:40 - 20:50
Presenter: Katharine Barnard-Kelly, UK

Author: Katharine Barnard-Kelly, UK; Nick Oliver, UK; Edward Franek, Poland; Iris Vesper, Germany; Tobias J. Etter, Germany; Florian Thienel, Germany; Julia K. Mader, Austria

View poster

Effects of the automatic calculation of prandial insulin bolus through a mobile phone application on A1C and quality of life in type1 diabetes people

E-Poster

Author: Cecilia Vargas, Francesca Gattini, Vicente Gutierrez, Paulina Vignolo, Augustina Guerrero, Kristel Strodthoff, Andrea Contreras

View poster

Improved glycemic control and diabetes distress after using an mHealth application: a preparation-analysis for the Digital Health Care Act in Germany

E-Poster

Author: Valerie Eichinger, Dominic Ehrmann, Johanna Kober, Marius Kraus, Vanessa Gerber, Norbert Hermanns, Bernhard Kulzer, Stephan Silbermann

View poster

A Novel Algorithm to Detect Priming Doses from Smart Insulin Pens

E-Poster

Author: Jan Wrede

View poster
  Order now

Receive Roche Diabetes Care solutions brochures and publications links via email!

Order now
 

Publications

Automated Bolus Advisor

Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes - The BolusCal Study, a randomized controlled pilot study

(Schmidt et al. Diabetes Care, 2012 May;35(5):984-90.)

Read publication

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial

(Ziegler et al. Diabetes Care. 2013 Nov; 36(11):3613-9.)

Read publication

SMBG – System Performance

System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose According to DIN EN ISO 15197

(Freckmann et al. J Diabetes Sci Technol. 2012 Sep 1;6(5):1060-75.)

Read publication

System accuracy evaluation of 18 CE marked current generation blood glucose monitoring systems based on EN ISO 15197:2015

(Pleus et al. BMJ Open Diabetes Res Care. 2020, 8(1): e001067)

Read publication

Structured Testing and Pattern Analysis

Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study

(Mora et al. Diabetes Technol Ther. 2017 Dec 1;19(12):715-22.)

Read publication

Evaluation of a new digital automated glycemic pattern detection tool

(Comellas et al. Diabetes Techno Ther. 2017 Nov 1;19(11):633-40)

Read publication

Use of Diabetes Data Management Software Reports by Health Care Providers, Patients With Diabetes, and Caregivers Improves Accuracy and Efficiency of Data Analysis and Interpretation Compared With Traditional Logbook Data: First Results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES)

(Hinnen et al. J Diabetes Sci Technol. 2015 Mar:9(2):293-301.)

Read publication

What Do We Need beyond Hemoglobin A1c to Get the Complete Picture of glycemia in people with diabetes?

(Hinzmann et al. Int. J Med Sci. 2012;9(8):665-81.)

Read publication

CGM

A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II

(Christiansen et al. Diabetes Technol. Ther. 2018 Jan 30 (Epub))

Read publication

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial

(Kropff et al. Diabetes Care 2017 Jan:40(1):63-68.)

Read publication

Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space

(Heinemann et al. J Diabetes Sci Technol. 2019 Jun (Epub))

Read publication

Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice

(Johnson et al. J Diabetes Sci Technol. 2019 Jun:21(S2):S217-5225.)

Read publication

Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space

(Heinemann et al. J Diabetes Sci Technol. 2020 Jan;14(1):135–150.)

Read publication

Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM

(Ziegler et al. J Diabetes Sci Technol. 2021 May;15(3):684-694.)

Read publication

Standardization process of continuous glucose monitoring: Traceability and performance

(Freckmann et al. Clin. Chim. Acta. 2021 Apr;515:5-12.)

Read publication

CSII

Boluses in insulin therapy: A Commentary

(Ziegler et al. J Diabetes Technol. 2017;11(1):165-71.)

Read publication

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study

(Steineck et al. BMJ 2015; 350: h3234.)

Read publication

Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?

(Barnard et al. J Diabetes Sci Technol. 2018 Nov;12(6):1223-1226)

Read publication

Patch Pumps: Are They All the Same?

(Heinemann et al. J Diabetes Sci Technol. 2019 Jan:13(1):34-40.)

Read publication

Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps

(Kamecke et al. J Diabetes Sci Technol. 2018; ePub)

Read publication

Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates

(Freckmann et al. J Diabetes Sci Technol. 2018;12(3):608-613)

Read publication

Continuous subcutaneous insulin infusion: Special needs for children

(Adolfsson et al. Pediatr. Diabetes 2017 Jan;18(4):225-261.)

Read publication

Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction

(Deeb et al. Clin. Diabetes Endocrinol. 2019 Jun 6;5:7.)

Read publication

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems

(Freckmann et al. Diabetes Technol. Ther. 2019 Apr;21(4):201-208)

Read publication

Comparative Handling Analysis of Different Insulin Pump Systems

(Waldenmaier et al. J Diabetes Sci Technol. 2018 Mar;12(2):401-406)

Read publication

Concept and Implementation of a Novel Patch Pump for Insulin Delivery

(Ulbrich et al. J Diabetes Sci Technol. 2019 Aug (Epub))

Read publication

Concept and Implementation of a Novel Patch Pump for Insulin Delivery

(Ulbrich et al. J Diabetes Sci Technol. 2020 Mar;14(2):324-327.)

Read publication

Analysis of the Waste Volume and CO 2-Equivalent Caused by the Use of Selected Patch Pumps

(Winkelkötter et al. J Diabetes Sci Technol. 2021 (Epub))

Read publication

Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies

(Freckmann et al. J Diabetes Sci Technol. 2020 (Epub))

Read publication

Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents

(Ziegler et al. Pediatr. Diabetes. 2020 Jun;21(4):649-656.)

Read publication

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion

(Ziegler et al. Diabetes Technol. Ther. 2021 May;23(5):350-357.)

Read publication

Digital Solutions

Utilizing eHealth and Telemedicine Technologies to Enhance Access and Quality

(Barnard et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

A Digital-First Model of Diabetes Care

(Cafazzo et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821))

Read publication

Real-World Assessments of mySugr Mobile Health App

(Debong et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy

(Forlenza et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care

(Garg et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Current Status and Future Directions for Electronic Point-of-Care Clinical Decision Support to Improve Diabetes Management in Primary Care

(O'Connor et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings - Lessons Learned from Emerging Economies

(Pradeepa et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)

Read publication

Virtual Coaching to Enhance Diabetes Care

(Ramchandani et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)

Read publication

Integrated Personalised Diabetes Management

Benefit of Digital Tools Used for Intergrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program

(Heinemann et al. J Diabetes Sci Technol. 2019 Aug (Epub))

Read publication

Patient-centred care in type 2 diabetes mellitus - key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report

(Fritzen et al. Diabetes Res. Clin. Pract. 2019 Dec (Epub))

Read publication

Intergrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program

(Kulzer et al. Diab. Res. Clin. Pract. 2018 Oct;144:200-2012)

Read publication

Intergrated Personalized Diabetes Management (PDM): Design of the ProValues Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.

(Kulzer et al. J Diabetes Sci Technol. 2016 May;10(3):722-781.)

Read publication

PDM-ProValue meets cardiovascular outcome trials in diabetes

(Fritzen et al. Cardiovasc. Diabetol. 2019 Jan 28;18(1):10)

Read publication

Chronic Kidney Disease

Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data

(Ravizza et al. Nat Med. 2019 Jan:25(1):57-59.)

Read publication

Other

Modeling of Diabetes and Its Clinical Impact

(Fritzen et al. Diabetes Sci Technol. 2018 Sep;12(5):976-984.)

Read publication

Diabetes management intervention studies: lessons learned from two studies

(Petersen et al. Trials, 2021 Jan 18;22(1):61.)

Read publication

CIPII

Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes

(Pasquini et al. Acta Diabetol. 2019 Aug 9.)

Read publication

A New Optimized Percutaneous Access System for CIPII

(Garcia-Verdugo et al. J Diabetes Sci Technol. 2019 Jul;11(4):814-821)

Read publication

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study

(Dassau et al. Diabetes Obs. Metab. 2017 Dec;19(12):1698-1705.)

Read publication

New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion

(Rieger et al. J Diabetes Sci Technol. 2019 Jun (Epub))

Read publication

Automated Insulin Delivery

Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes

(Brown et al. Clin. Endocrinol. Metab. 2017 Oct 1;102(10):3674-3682.)

Read publication

Twelve-week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin a1c and Hypoglycemia

(Dassau et al. Diabetes Care 2018 Dec;40(12):1719-1726.)

Read publication

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study

(Breton et al. Diabetes Care 2017 Dec;40(12):1644-1650.)

Read publication

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes

(Cameron et al. Diabetes Technol. Ther. 2017 Sep;19(9):527-532.)

Read publication

Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses

(Sanchez-Pena et al. J Diabetes Sci Technol. 2018 Sep;12(5):914-925.)

Read publication

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp.

(Ly et al. Diabetes Care 2016 Aug;39(8):e 106-7.)

Read publication

Outpatient Closed-Loop Control With Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control

(Huyett et al. Diabetes Technol. Ther. 2017 Jun;19(6):331-339.)

Read publication

Randomized Controlled Trial of Mobile Closed-Loop Control

(Kovatchev et al. Diabetes Care 2020 Mar;43(3):607-615.)

Read publication
 

Brochures - Our Solutions

Highlights

Accu-Chek Insight Loop Mode

  • Intelligent: DBLG1 algorithm analyses data in real time and is a self-learning algorithm, meaning it adapts to every individual.
  • Control everything with one device: Insulin and CGM values
  • Pre-filled NovoRapid insulin cartridge: No need to fill it by hand
View brochure

RocheDiabetes Care Platform

  • All-in-one platform which enables integrated Personalised Diabetes Management (iPDM)
  • Seamless connection with +140 diabetes management devices and mySugr patient app, encouraging diabetes self-management
  • Actionable insights for more efficient consultations
  • Patient tracking and therapy adjustment for personalised care
  • Under constant evolution to support you now and in the future
View brochure

RocheDiabetes RemoteCare

  • Visualisation of all your patients at a glance to easily understand their status and prioritise them according to their needs
  • Quick and comprehensive picture of how patients are doing between visits, enabling remote interventions for continuous care
  • Two-way dialogue between HCPs and patients to enable proactive, flexible, and efficient care even at a distance
  • Recordings of observations and time spent providing remote care for potential reimbursement
View brochure

mySugr Pump Control

  • All data in one place: Patients can manage their CGM, BGM and pump data in just one app*.
  • Discretion: Send a bolus via the mySugr app discreetly anywhere, anytime.
  • Open bolus advisor: Directly accessible via the mySugr app
  • Freedom of choice: Choose from two pre-filled cartridges - Fiasp or NovoRapid.

*For all mySugr supported devices

View brochure

Accu-Chek Solo

  • First detachable and tube-free insulin pump 
  • Unique quick bolus buttons on pump
  • Diabetes Manager with open bolus advice to combine therapy with continuous glucose monitoring solutions
  • Connected to the RocheDiabetes Care Platform, allowing the combined visualisation of insulin and blood glucose data to detect therapy patterns and improve outcomes 
View brochure

Smart Pen Integration in mySugr Logbook

  • All-in-one: Manage glucose levels, insulin, and carb data in just one app.
  • Easy: Automated logging of insulin time and dose together with glucose values
  • Multiple pen pairing: Option to connect up to 8 pens
  • Intuitive visualisation: Valuable insights on patterns and therapy effectiveness
View brochure

More solution brochures

mySugr app

  • More than 3 million registered users
  • Automated data integration of leading BG meters (e.g. Accu-Chek Guide), CGM and activity data from cloud-based integrations Apple health (Dexcom G5/G6) and Google Fit (steps)
  • mySugr PRO includes bolus calculator.
  • Comprehensive reports to share from the mySugr app with HCPs
  • New integrations:
    - RocheDiabetes Care Platform: Integration of BG values, carb information, CGM, and insulin data into RDCP
    - Smart insulin pen integration: Integration of insulin data from the NovoPen 6 and NovoPen Echo Plus into the mySugr Logbook
    - mySugr Pump Control: Accu-Chek Insight is the first insulin pump to be controlled and viewed via the mySugr app.
View brochure

RocheDiabetes InsulinStart

  • Guided process that provides clear, actionable advice to the person with diabetes, for a safe and effective start at insulin therapy
  • Proven algorithms help people with diabetes find their optimum insulin dosage
  • Add-on to the Accu-Chek Smart Pix software
View brochure

Accu-Chek Smart Pix

  • Open version allows for read-out of devices from Roche and other manufacturers
  • All data seamlessly available in one system
  • Easy and fast conclusions and therapy adaptations possible
  • Easily understandable visualisation of different diabetes-relevant data

Accu-Chek Insight Classic

  • Easy and intuitive: Pre-filled insulin cartridges - no need to fill by hand.
  • Convenient: Sleek and modern design makes it more comfortable to wear.
  • Safe and reliable: Very low basal rate to suit individual insulin needs, pause mode ensures missed insulin is delivered and various bolus options available
View brochure

Accu-Chek Guide

  • Spill-resistant SmartPack vial: Easy to take out one strip at a time
  • Simple to see, day or night: Bright port light and backlit display
  • Wide dosing area: Simply touch any part of the yellow edge to your blood drop.
  • Connects to mySugr app and RocheDiabetes Care Platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure

Accu-Chek Guide Me

  • Large, easy-to-read display
  • Simple two-button navigation
  • Fast, easy-to-fill strip with results in less than 4 seconds
  • Wireless connectivity to the mySugr app
View brochure

Accu-Chek Instant

  • Instant understanding: The target range indicator provides an instant view to see if your result is high, low, or in range.
  • Easy to read: Clearly see results on the large backlit display.
  • Easy testing: Apply blood on the edge of the wide application area.
  • Connects to mySugr app and RocheDiabetes Care Platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure

Accu-Chek SugarView

  • All you need is a smartphone, an Accu-Chek Active blood glucose test strip, a lancet, and the app to see your blood glucose test range and know what to do.
  • Feel motivated and assured about your type 2 diabetes as you know your next step.
  • Know how you are doing in between your doctor's appointments in an affordable way.
  • Useful to enable integrated Personalised Diabetes Management (iPDM).

Visit us

We look forward to welcoming you to the virtual Roche Diabetes Care presence!

Visit our Roche Diabetes Care Showroom and chat with booth staff on integrated Personalised Diabetes Management. Feel free to contact us for more information and visit our website.

This website contains information on products that are targeted to a wide range of audiences and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for ac-cessing such information that may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

© 2021 Roche Diabetes Care. All rights reserved.